Characterizing LNP: Meeting Regulatory Expectations with FFF-MALS

Learn how FFF-MALS enables comprehensive characterization of lipid nanoparticles and liposomal drug products. Discover practical implementation for measuring regulatory-relevant CQAs with confidence.

Register Free: https://www.biopharminternational.com/bp_w/lnp

Event Overview:

Developing safe and effective lipid nanoparticle (LNP) and liposomal therapeutics depends on accurate characterization of critical quality attributes throughout development and manufacturing.

In this webinar, we'll review evolving regulatory expectations from the FDA, EMA, and USP and discuss why attributes such as particle size, size distribution, surface charge, and particle morphology are essential for product quality. We'll then introduce field-flow fractionation coupled with multi-angle light scattering (FFF-MALS) as a versatile analytical platform that provides size-resolved characterization while preserving native particle structure.

Through practical examples and implementation guidance, attendees will learn how FFF-MALS can strengthen analytical workflows and support regulatory-ready characterization.

Key Learning Objectives:

• Review recent and upcoming regulatory changes affecting LNP and liposomal drug critical quality attributes.
  
• Learn how FFF‑MALS can address critical quality attributes.
  
• Discover resources and practical tips for implementation.

Who Should Attend:

This webinar is designed for scientists, analysts, and lab managers working on vaccine, lipid nanoparticle (LNP), or liposome characterization, as well as professionals at CDMOs, CROs, and testing organizations looking to expand their analytical capabilities.

Speaker:

Udayabagya (Bud) Halim, PhD
Principal Product Marketing Manager
Waters | Wyatt Technology

Bud Halim is a principal product marketing manager at Waters | Wyatt Technology. He has a PhD in physical chemistry from UCLA. He supports product development and scientific marketing for analytical instrumentation used to characterize large macromolecules including peptides, biologics, lipid nanoparticles, and viral vectors.

Register Free: https://www.biopharminternational.com/bp_w/lnp